We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Great Southern Bancorp
GSBC
$880M
| $2.11M | ﹤0.01% |
36,064
-2,975
| -8% | -$173K |
|
|
CIVI
1077
DELISTED
Civitas Resources
CIVI
| $2.11M | ﹤0.01% |
40,291
-6,250
| -13% | -$408K |
|
|
HTLF
1078
DELISTED
Heartland Financial USA, Inc.
HTLF
| $2.1M | ﹤0.01% |
50,628
-1,505
| -3% | -$66.2K |
|
1079
Trex
TREX
$4.94B
| $2.1M | ﹤0.01% |
39,509
+27,518
| +229% | +$1.66M |
|
1080
Equity Lifestyle Properties
ELS
$12.3B
| $2.1M | ﹤0.01% |
29,795
-125,984
| -81% | -$9.4M |
|
1081
SFL Corp
SFL
$1.56B
| $2.1M | ﹤0.01% |
221,320
-26,618
| -11% | -$277K |
|
1082
RLI Corp
RLI
$5.79B
| $2.09M | ﹤0.01% |
36,544
+21,344
| +140% | +$1.22M |
|
1083
Winmark
WINA
$1.28B
| $2.08M | ﹤0.01% |
10,630
-1,223
| -10% | -$251K |
|
|
VSTO
1084
DELISTED
Vista Outdoor Inc.
VSTO
| $2.08M | ﹤0.01% |
74,363
+2,698
| +4% | +$96.3K |
|
1085
Forrester Research
FORR
$227M
| $2.06M | ﹤0.01% |
43,121
+4,071
| +10% | +$211K |
|
1086
Sysco
SYY
$39.9B
| $2.06M | ﹤0.01% |
24,704
+1,340
| +6% | +$112K |
|
1087
MACOM Technology Solutions
MTSI
$24.3B
| $2.06M | ﹤0.01% |
44,659
-3,856
| -8% | -$199K |
|
|
PETQ
1088
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $2.05M | ﹤0.01% |
122,062
+107,386
| +732% | +$1.97M |
|
|
FLIC
1089
DELISTED
First of Long Island Corp
FLIC
| $2.05M | ﹤0.01% |
116,791
+33,733
| +41% | +$623K |
|
1090
National Presto Industries
NPK
$995M
| $2.03M | ﹤0.01% |
30,949
+16,379
| +112% | +$1.16M |
|
1091
Piper Sandler
PIPR
$5.35B
| $2.03M | ﹤0.01% |
71,540
-47,340
| -40% | -$1.43M |
|
1092
Bristow Group
VTOL
$1.36B
| $2.02M | ﹤0.01% |
86,508
+32,658
| +61% | +$963K |
|
|
ARNC
1093
DELISTED
Arconic Corporation
ARNC
| $2.02M | ﹤0.01% |
71,852
-13,098
| -15% | -$354K |
|
1094
Extreme Networks
EXTR
$3.24B
| $2M | ﹤0.01% |
224,338
-1,525
| -0.7% | -$15.5K |
|
|
AHRT
1095
AH Realty Trust
AHRT
$501M
| $1.99M | ﹤0.01% |
155,004
-5,477
| -3% | -$74.4K |
|
1096
Seaboard Corp
SEB
$4.07B
| $1.99M | ﹤0.01% |
512
+23
| +5% | +$92.8K |
|
|
SVC
1097
Service Properties Trust
SVC
$1.08B
| $1.99M | ﹤0.01% |
79,924
+19,962
| +33% | +$689K |
|
|
ZEUS
1098
DELISTED
Olympic Steel
ZEUS
| $1.98M | ﹤0.01% |
77,014
+54,798
| +247% | +$1.85M |
|
|
BRKL
1099
DELISTED
Brookline Bancorp
BRKL
| $1.98M | ﹤0.01% |
148,894
+44,123
| +42% | +$634K |
|
|
SHYF
1100
DELISTED
The Shyft Group
SHYF
| $1.97M | ﹤0.01% |
106,007
+68,238
| +181% | +$1.67M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.